比较未破裂颅内动脉瘤外科夹闭与血管内治疗的实用性随机试验
该随机试验纳入291例3–25 mm未破裂颅内动脉瘤患者,比较夹闭与血管内治疗的安全性和有效性。1年主要复合结局(动脉瘤未闭塞、随访期颅内出血或1年残留动脉瘤)在手术组为9%,血管内治疗组为19%(相对风险2.07,P=0.021);手术组新发神经功能缺损和住院超过5天更常见,而1年mRS>2的并发症和死亡率两组均为2%。
要点
- 未破裂颅内动脉瘤夹闭组1年治疗失败率9%,血管内治疗组19%,相对风险2.07(95%CI 1.12-3.83)。
- 手术组新发神经功能缺损22%,血管内治疗组12%;住院超过5天分别为48%和8%。
- 1年mRS>2的并发症和死亡率两组均为2%,差异无统计学意义。
核心结论
- 在未破裂颅内动脉瘤中,外科夹闭的治疗失败主要复合结局发生率低于血管内治疗,结果主要由1年血管造影结果驱动。
研究设计与样本
- 实用性随机试验,2010至2020年7个中心纳入291例有1个或多个3–25 mm未破裂颅内动脉瘤且经参与医师判断两种方式均可治疗的患者,随机分配至夹闭或血管内治疗,无盲法;主要复合结局由核心实验室裁定。
诊断标准与关键数值
- 主要复合结局定义为动脉瘤未闭塞、随访期颅内出血或1年残留动脉瘤;1年主要结局在290/291(99%)患者中可确定,夹闭组13/142(9%;95%CI 5%-15%),血管内治疗组28/148(19%;95%CI 13%-26%),相对风险2.07(95%CI 1.12-3.83;P=0.021)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 研究未设盲。
- 原文结论未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Surgical clipping and endovascular treatment are commonly used in patients with unruptured intracranial aneurysms. We compared the safety and efficacy of the 2 treatments in a randomized trial.
MATERIALS AND METHODS: Clipping or endovascular treatments were randomly allocated to patients with one or more 3- to 25-mm unruptured intracranial aneurysms judged treatable both ways by participating physicians. The study hypothesized that clipping would decrease the incidence of treatment failure from 13% to 4%, a composite primary outcome defined as failure of aneurysm occlusion, intracranial hemorrhage during follow-up, or residual aneurysms at 1 year, as adjudicated by a core lab. Safety outcomes included new neurologic deficits following treatment, hospitalization of >5 days, and overall morbidity and mortality (mRS > 2) at 1 year. There was no blinding.
RESULTS: Two hundred ninety-one patients were enrolled from 2010 to 2020 in 7 centers. The 1-year primary outcome, ascertainable in 290/291 (99%) patients, was reached in 13/142 (9%; 95% CI, 5%-15%) patients allocated to surgery and in 28/148 (19%; 95% CI, 13%-26%) patients allocated to endovascular treatments (relative risk: 2.07; 95% CI, 1.12-3.83; P = .021). Morbidity and mortality (mRS >2) at 1 year occurred in 3/143 and 3/148 (2%; 95% CI, 1%-6%) patients allocated to surgery and endovascular treatments, respectively. Neurologic deficits (32/143, 22%; 95% CI, 16%-30% versus 19/148, 12%; 95% CI, 8%-19%; relative risk: 1.74; 95% CI, 1.04-2.92; P = .04) and hospitalizations beyond 5 days (69/143, 48%; 95% CI, 40%-56% versus 12/148, 8%; 95% CI, 5%-14%; relative risk: 0.18; 95% CI, 0.11-0.31; P < .001) were more frequent after surgery.
CONCLUSIONS: Surgical clipping is more effective than endovascular treatment of unruptured intracranial aneurysms in terms of the frequency of the primary outcome of treatment failure. Results were mainly driven by angiographic results at 1 year.
引用
- Darsaut, Findlay, Bojanowski, et al. A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms. AJNR Am J Neuroradiol. 2023. PMID: 37169541. doi:10.3174/ajnr.A7865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。